Manufacturing News
MS Pharma Group Partners with Hetero to Localize Five Biosimilars in Algeria
MS Pharma Group has entered into a strategic partnership with Hetero Group to localize five established biosimilars across oncology, immunology, and hematology in Algeria. The agreement aims to expand access to biologic medicines through a localization and technology transfer approach.
27 January 2026